NGM BIOPHARMACEUTICALS INC Operating Lease Right-of-Use Assets
NGM BIOPHARMACEUTICALS INC had Operating Lease Right-of-Use Assets of $0 as of 2023-12-31, per its 10-K filed 2024-03-11.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2024-03-11
- 2023-12-31: Operating Lease, Right-of-Use Asset $0.00.
- 2023-09-30: Operating Lease, Right-of-Use Asset $538.00K.
- 2023-06-30: Operating Lease, Right-of-Use Asset $1.07M.
- 2023-03-31: Operating Lease, Right-of-Use Asset $1.59M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-11 |
| 2023-09-30 | $538.00K 10-Q · filed 2023-11-02 |
| 2023-06-30 | $1.07M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $1.59M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $2.10M 10-K · filed 2024-03-11 |
| 2022-09-30 | $2.60M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $3.09M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $3.57M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $4.04M 10-K · filed 2023-02-28 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-01 |